Opexa Therapeutics, Inc. (OPXA) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q2 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $307.7 thousand versus the consensus estimate of $330 thousand.
For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Mangoceuticals closes $500K offering at 74% premium to recent price
- UBS Reiterates Buy Rating on Pepsico (PEP) on Q3 Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
